Latest in Cardiology from ACC.org

• ACCEL Lite: Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial
  Caffeinated coffee may reduce the risk of atrial fibrillation through several proposed mechanisms, including improved autonomic balance, antioxidant effects, and enhanced vascular function.
• ACC.26 Convocation Incoming President’s Address: Roxana Mehran, MD, FACC
  Incoming ACC President Roxana Mehran reflects on her journey, honors mentors and calls the cardiovascular community to lead with innovation, compassion and collaboration.
• ACC.26 Convocation Outgoing President’s Address: Christopher Kramer, MD, MACC
  Outgoing ACC President Christopher Kramer addresses scientific advances, global collaboration, advocacy wins and a year of leadership across the cardiovascular community.
• FUND-HF: Financial Support Improves Medication Adherence in Vulnerable Patients
  Providing financial support early after hospital discharge to economically vulnerable patients with heart failure (HF) with reduced ejection fraction is feasible and significantly improved adherence to prescribed medications, according to results from the FUND-HF pilot trial presented during an Investigative Horizons session at ACC.26 in New Orleans and simultaneously published in JACC.
• IVUS-CHIP and OPTIMAL: IVUS-Guided vs. Angiography-Guided PCI
  When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with unprotected left main coronary artery disease (LM-CAD) according to results from the OPTIMAL trial. Both trials were presented in a Late-Breaking Clinical Trial session at […]